<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>equitable vaccine distribution — GZERO Media</title>
<link>https://www.gzeromedia.com/tag/equitable-vaccine-distribution</link>
<description>The latest news and analysis from GZERO Media.</description>
<language>en</language>
<copyright>© GZERO Media</copyright>
<atom:link href="https://www.gzeromedia.com/feeds/tag/equitable-vaccine-distribution.xml" rel="self" type="application/rss+xml" />
<lastBuildDate>Sat, 12 Mar 2022 23:00:00 +0000</lastBuildDate>
<item>
<title>After COVID vaccines, time to use mRNA tech against other infectious diseases</title>
<link>https://www.gzeromedia.com/video/gzero-live/after-covid-vaccines-time-to-use-mrna-tech-against-other-infectious-diseases</link>
<guid isPermaLink="false">cmvrevt4ehwb807lq0qeicodh</guid>
<pubDate>Sat, 12 Mar 2022 23:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>gates foundation</category>
<category>melanie saville</category>
<category>equitable vaccine distribution</category>
<category>covid-19</category>
<category>mrna</category>
<category>science-tech</category>
<category>vaccines</category>
<category>infectious diseases</category>
<category>GZERO Live</category>
<description>Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough. But that&apos;s just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill &amp; Melinda Gates Foundation. &quot;There&apos;s still a lot that should be done with the technology moving forward&quot; on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb5jwy8sl907myp1qu6gjt" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb5jwy8sl907myp1qu6gjt" />
<content:encoded><![CDATA[<p>Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.</p><p>But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill &amp; Melinda Gates Foundation. "</p><p>There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.</p><p>Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.<br></p>]]></content:encoded>
</item>
</channel>
</rss>